Pharmacogenomics of Anti-TNF (Anti-tumor Necrosis Factor) Treatment in Patients With Rheumatoid Arthritis

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

NCT02878161 ·Status: UNKNOWN ·Phase: PHASE4

Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents

NCT01691014 ·Status: TERMINATED

Serum Biomarkers Analysis in Patients With AR Treated With Anti-TMF

NCT02804204 ·Status: UNKNOWN

Drug Outcome Survey for Biological Treatments in Rheumatoid Arthritis: an Observational Study (Dose)

NCT00794118 ·Status: COMPLETED

Prediction of Methotrexate Response - A Pilot Study

NCT01726959 ·Status: COMPLETED

Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA

NCT04078191 ·Status: TERMINATED ·Phase: PHASE2

Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France

NCT02927509 ·Status: COMPLETED

A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)

NCT00724672 ·Status: WITHDRAWN

Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease

NCT02742337 ·Status: UNKNOWN

Biomarkers of Anti-TNF-α Therapy Efficacy in Rheumatoid Arthritis to Define Unresponsive Patients

NCT01211678 ·Status: COMPLETED

Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France

NCT02927535 ·Status: COMPLETED

Evaluation of the Efficacy of Combination Treatment With Anakinra and Pegsunercept in Improving Rheumatoid Arthritis

NCT00037700 ·Status: COMPLETED ·Phase: PHASE2

Faecal Analyses in Rheumatoid Arthritis Therapy

NCT03775824 ·Status: COMPLETED

Long-Term Safety Follow-Up Of Subjects Previously Enrolled In Rheumatoid Arthritis Studies Of CP-690,550

NCT00414661 ·Status: COMPLETED

Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA

NCT05246280 ·Status: TERMINATED ·Phase: PHASE3

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

NCT00929357 ·Status: COMPLETED

An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.

NCT02590562 ·Status: COMPLETED

Biomarkers in Chronic Arthritis

NCT02909998 ·Status: COMPLETED

Relation of IL23R and IL17A Gene Polymorphisms Plus Serum Levels of IL23 and IL17A to Rheumatoid Arthritis Susceptibility and Activity

NCT05570513 ·Status: NOT_YET_RECRUITING

To Investigate Genetic Factors Associated With the Response to Anti-TNF Therapy in Patients With Early AS

NCT02311842 ·Status: COMPLETED

Study During Pregnancy of Expression of miRNAs in RA or SLE

NCT02350491 ·Status: COMPLETED

TNF and IL23 Blocking Agents Gene Expression Ratios in the Psoriatic Arthritis Synovium_(TIGERS) Study

NCT04261010 ·Status: COMPLETED ·Phase: NA

Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)

NCT00256919 ·Status: COMPLETED ·Phase: PHASE2

Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis

NCT00213538 ·Status: COMPLETED

A Study to Evaluate the RNA Signature of Rheumatoid Arthritis From Synovium and Whole Blood

NCT00781469 ·Status: TERMINATED